Recombinant Human Interferon-Α1b Inhibits SARS-CoV-2 Better Than Interferon-Α2b in Vitro

Daqing Shi,Keda Chen,Xiangyun Lu,Linfang Cheng,Tian-Hao Weng,Fumin Liu,Nanping Wu,Lanjuan Li,Hang‐Ping Yao

DOI: https://doi.org/10.1016/j.virs.2022.01.031

2022-01-01

Abstract:• A comprehensive evaluation method for anti-SARS-CoV-2 drugs was established based on qPCR, TCID 50 , and immunofluorescence. • A significant antiviral effect of rHuIFN-α1b was shown in Vero and Calu-3 ​cells. • rHuIFN-α1b has a good potential in the application of anti-COVID-19 therapy.